Inflammation in ALS and SMA: sorting out the good from the evil
- PMID: 19833209
- PMCID: PMC2823924
- DOI: 10.1016/j.nbd.2009.10.005
Inflammation in ALS and SMA: sorting out the good from the evil
Abstract
Indices of neuroinflammation are found in a variety of diseases of the CNS including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Over the years, neuroinflammation, in degenerative disorders of the CNS, has evolved from being regarded as an innocent bystander accomplishing its housekeeping function secondary to neurodegeneration to being considered as a bona fide contributor to the disease process and, in some situations, as a putative initiator of the disease. Herein, we will review neuroinflammation in both ALS and SMA not only from the angle of neuropathology but also from the angle of its potential role in the pathogenesis and treatment of these two dreadful paralytic disorders.
2009 Elsevier Inc. All rights reserved.
Similar articles
-
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.Neurobiol Dis. 2008 Sep;31(3):395-405. doi: 10.1016/j.nbd.2008.05.016. Epub 2008 Jun 4. Neurobiol Dis. 2008. PMID: 18586098
-
Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease?Muscle Nerve. 2007 Jun;35(6):712-24. doi: 10.1002/mus.20768. Muscle Nerve. 2007. PMID: 17373702 Review.
-
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.Nat Neurosci. 2008 Mar;11(3):251-3. doi: 10.1038/nn2047. Epub 2008 Feb 3. Nat Neurosci. 2008. PMID: 18246065 Free PMC article.
-
Innate immunity in amyotrophic lateral sclerosis.Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1083-93. doi: 10.1016/j.bbadis.2006.03.001. Epub 2006 Mar 31. Biochim Biophys Acta. 2006. PMID: 16624536 Review.
-
Motoneuron disease.Handb Exp Pharmacol. 2014;220:411-41. doi: 10.1007/978-3-642-45106-5_15. Handb Exp Pharmacol. 2014. PMID: 24668481 Review.
Cited by
-
Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy.Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19348-53. doi: 10.1073/pnas.1319280110. Epub 2013 Nov 4. Proc Natl Acad Sci U S A. 2013. PMID: 24191055 Free PMC article.
-
Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS).PLoS One. 2011 Mar 18;6(3):e17187. doi: 10.1371/journal.pone.0017187. PLoS One. 2011. PMID: 21445241 Free PMC article.
-
Complex Inflammation mRNA-Related Response in ALS Is Region Dependent.Neural Plast. 2015;2015:573784. doi: 10.1155/2015/573784. Epub 2015 Aug 2. Neural Plast. 2015. PMID: 26301107 Free PMC article.
-
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models.Nat Commun. 2017 Oct 27;8(1):1164. doi: 10.1038/s41467-017-01283-z. Nat Commun. 2017. PMID: 29079839 Free PMC article.
-
Present State and Future Perspectives of Prostaglandins as a Differentiation Factor in Motor Neurons.Cell Mol Neurobiol. 2022 Oct;42(7):2097-2108. doi: 10.1007/s10571-021-01104-4. Epub 2021 May 25. Cell Mol Neurobiol. 2022. PMID: 34032949 Free PMC article. Review.
References
-
- Almer G, Guégan C, Teismann P, Naini A, Rosoklija G, Hays AP, Chen C, Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol. 2001;49:176–185. - PubMed
-
- Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1999;72:2415–2425. - PubMed
-
- Apostolski S, Nikolic J, Bugarskiprokopljevic C, Miletic V, Pavlovic S, Filipovic S. Serum and Csf Immunological Findings in Als. Acta Neurol Scand. 1991;83:96–98. - PubMed
-
- Araki S, Hayashi M, Tamagawa K, Saito M, Kato S, Komori T, Sakakihara Y, Mizutani T, Oda A. Neuropathological analysis in spinal muscular atrophy type II. Acta Neuropathologica. 2003;106:441–448. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS11766/NS/NINDS NIH HHS/United States
- P50 NS038370/NS/NINDS NIH HHS/United States
- R21 NS062180-01/NS/NINDS NIH HHS/United States
- NS042269/NS/NINDS NIH HHS/United States
- R01 AG021617-05/AG/NIA NIH HHS/United States
- R01 NS051419/NS/NINDS NIH HHS/United States
- R21 NS064191/NS/NINDS NIH HHS/United States
- P01 NS011766/NS/NINDS NIH HHS/United States
- NS062180/NS/NINDS NIH HHS/United States
- R01 NS062055/NS/NINDS NIH HHS/United States
- R21 NS062180-02/NS/NINDS NIH HHS/United States
- NS062055/NS/NINDS NIH HHS/United States
- R01 AG021617/AG/NIA NIH HHS/United States
- P01 NS011766-310040/NS/NINDS NIH HHS/United States
- NS38370/NS/NINDS NIH HHS/United States
- P50 NS038370-115286/NS/NINDS NIH HHS/United States
- R01 NS042269-04/NS/NINDS NIH HHS/United States
- R21 NS064191-01A1/NS/NINDS NIH HHS/United States
- R21 NS062180/NS/NINDS NIH HHS/United States
- AG 21617/AG/NIA NIH HHS/United States
- R01 NS042269-05A2/NS/NINDS NIH HHS/United States
- R21 NS072182/NS/NINDS NIH HHS/United States
- NS064191/NS/NINDS NIH HHS/United States
- R01 NS062055-01A1/NS/NINDS NIH HHS/United States
- R01 NS042269/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous